Using ‘omics To Unravel The Pathophysiology And Repurpose Drugs To Treat ME/CFS
Funder
National Health and Medical Research Council
Funding Amount
$1,083,010.00
Summary
The cause(s) of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not well known, but may involve altered function by the component of the cell that produces energy (mitochondria). We will use cutting edge stem cell technology to investigate this in detail and generate vital new knowledge that could identify new targets for the treatment of ME/CFS. We will also use a complex technology to screen a library of drugs to identify those that may be useful in the treatment of ME/CFS.